Table 1 Clinical characteristics of the patients with P. jirovecii pneumonia
Patients with prolonged use of a moderate-to-high corticosteroid dose (n = 6) | Patients without prolonged use of a moderate-to-high corticosteroid dose (n = 14) | Total (n = 20) | |
|---|---|---|---|
Age (years), median (range) | 56 (46–76) | 67 (40–90) | 66 (40–90) |
Cancer type, n (%) | |||
Lung cancer | 1 (17) | 5 (36) | 6 (30) |
Breast cancer | 1 (17) | 2 (14) | 3 (15) |
Esophageal cancer | 0 (0) | 2 (14) | 2 (10) |
Pancreatic cancer | 1 (17) | 1 (7) | 2 (10) |
Othersa | 3 (50) | 4 (29) | 7 (35) |
ALC, n (%) | |||
< 500 | 3 (50) | 9 (64) | 12 (60) |
500–999 | 2 (33) | 4 (29) | 6 (30) |
≥ 1000 | 1 (17) | 1 (7) | 2 (10) |
LDH (Units/L) | |||
< 250 | 1 (17) | 2 (14) | 3 (15) |
250–500 | 4 (67) | 9 (64) | 13 (65) |
> 500 | 1 (17) | 3 (21) | 4 (20) |
BDG, median (range) | 85.8 (19.8–522.1) | 37.8 (16− > 600) | 45 (16− > 600) |
Main Radiologic findings, n (%) | |||
Ground glass opacities | 5 (83) | 13 (93) | 18 (90) |
Otherb | 1 (17) | 1 (7) | 2 (10) |